Bristol-Myers Squibb Co (NYSE:BMY)

57.38
BATS BZX Real-Time Price
As of 11:17am ET
 -1.89 / -3.19%
Today’s Change
45.76
Today|||52-Week Range
68.34
-10.61%
Year-to-Date
Roche's Tecentriq + Avastin Gets Positive CHMP Opinion for HCC
10:06am / Zacks.com - Paid Partner Content
Why Ziopharm Oncology Shares Zoomed Higher Today
Sep 14 / MotleyFool.com - Paid Partner Content
BMY/Exelixis Opdivo + Cabometyx shows survival benefits in late-stage kidney cancer study
7:22am / Seeking Alpha - Paid Partner Content
The Zacks Analyst Blog Highlights: Facebook, McDonald's, Bristol-Myers Squibb, Netflix, and U.S. Bancorp
Sep 14 / Zacks.com - Paid Partner Content
Tracking David Rolfe's Wedgewood Partners Portfolio - Q2 2020 Update
Sep 20 / Seeking Alpha - Paid Partner Content
The Extreme Risks of Trading Your Own Retirement Assets - September 14, 2020
Sep 14 / Zacks.com - Paid Partner Content
3 Dividend Stocks to Buy on Sale
Sep 20 / MotleyFool.com - Paid Partner Content
2 No-Brainer Stocks to Buy In Pharma
Sep 14 / MotleyFool.com - Paid Partner Content
3 Top Biotech Picks for 2025
Sep 20 / MotleyFool.com - Paid Partner Content
Dividends And Reasonable Price Appreciation: Introducing The 'DARPA' Portfolio
Sep 13 / Seeking Alpha - Paid Partner Content
50 Billionaire Holdings, 27 Pay Dividends, 2 To Buy In September
Sep 18 / Seeking Alpha - Paid Partner Content
Got $5,000? 3 Surefire Stocks to Buy Ahead of the Next Market Crash
Sep 13 / MotleyFool.com - Paid Partner Content
Why Pfizer Is Seriously Mispriced
Sep 18 / GuruFocus News - Paid Partner Content
Seeking Alpha Catalyst Watch
Sep 11 / Seeking Alpha - Paid Partner Content
Dr. Reddy's Settles Revlimid Patent Suit With Bristol Myers
Sep 18 / Zacks.com - Paid Partner Content
IPO Update: Metacrine Seeks $85 Million U.S. IPO
Sep 11 / Seeking Alpha - Paid Partner Content
European advisory group backs Bristol-Myers' Opdivo + Yervoy as first-line treatment in lung cancer
Sep 18 / Seeking Alpha - Paid Partner Content
Top Research Reports for Facebook, McDonalds & Bristol-Myers
Sep 11 / Zacks.com - Paid Partner Content
The Truth: Your S&P 500 ETF Is Riskier Than You Realize
Sep 18 / Seeking Alpha - Paid Partner Content
Jounce Therapeutics: An Undervalued Biotech Flush With Big Pharma Cash
Sep 11 / Seeking Alpha - Paid Partner Content
3 Cheap Stocks You Can Buy and Hold for Decades
Sep 18 / MotleyFool.com - Paid Partner Content
I'm Investing $50,000 In These Dividend-Paying Companies
Sep 11 / Seeking Alpha - Paid Partner Content
Bristol-Myers Squibb Cuts Deal, Delaying Threat to Top-Selling Revlimid
Sep 17 / MotleyFool.com - Paid Partner Content
3 Incredibly Strong Stocks to Buy That Should Thrive Even If the Stock Market Crashes Again
Sep 11 / MotleyFool.com - Paid Partner Content
Taysha Gene Therapies Seeks $125 Million IPO For Ambitious Pipeline
Sep 17 / Seeking Alpha - Paid Partner Content
Bristol Myers Squibb Declares Fresh Dividend; Yield Is 3.1%
Sep 10 / MotleyFool.com - Paid Partner Content
Corcept's Lead Drug Korlym Aids Growth, Heavy Reliance a Woe
Sep 17 / Zacks.com - Paid Partner Content
Bristol Myers Squibb (BMY) Stock Moves -1.34%: What You Should Know
Sep 10 / Zacks.com - Paid Partner Content
A Unique Security at a 68% Discount to Fair Value
Sep 17 / GuruFocus News - Paid Partner Content
Bristol Myers Squibb declares $0.45 dividend
Sep 10 / Seeking Alpha - Paid Partner Content
Bristol-Myers' Opdivo+Yevroy Application Gets EMA Validation
Sep 17 / Zacks.com - Paid Partner Content
3 Top Dividend Stocks to Maximize Your Retirement Income - September 10, 2020
Sep 10 / Zacks.com - Paid Partner Content
Bristol Myers settles Revlimid patent dispute with Dr. Reddy's
Sep 17 / Seeking Alpha - Paid Partner Content
Mid-stage study underway on VBL's VB-111 in colorectal cancer
Sep 10 / Seeking Alpha - Paid Partner Content
Bristol Myers O+Y shows long-term survival benefit in kidney cancer
Sep 17 / Seeking Alpha - Paid Partner Content
20 More Stocks I Hope To Buy During The Next Market Sell-Off (High Yield Edition)
Sep 10 / Seeking Alpha - Paid Partner Content
422 Stocks to Supplement Your Social Security Income
Sep 17 / MotleyFool.com - Paid Partner Content
Easy Investing Secrets to an Early Retirement - September 09, 2020
Sep 09 / Zacks.com - Paid Partner Content
Bristol Myers Squibb (BMY) Stock Moves -0.13%: What You Should Know
Sep 16 / Zacks.com - Paid Partner Content
Calithera Terminating Partnership, And Other News: The Good, Bad And Ugly Of Biopharma
Sep 09 / Seeking Alpha - Paid Partner Content
The Bristol-Myers CVR Is Worth $7.83
Sep 15 / Seeking Alpha - Paid Partner Content
Is bluebird bio Stock a Buy?
Sep 09 / MotleyFool.com - Paid Partner Content
The Bristol-Myers CVR Is Worth $6.93
Sep 15 / Seeking Alpha - Paid Partner Content
September 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma
Sep 09 / Seeking Alpha - Paid Partner Content
Merger Monday Confirms An Active Stock Market - Buy Under-Appreciated Biotech
Sep 15 / Seeking Alpha - Paid Partner Content
Bristol-Myers Squibb Company (BMY) Management Presents at Citi 15th Annual Biopharma Conference (Transcript)
Sep 09 / Seeking Alpha - Paid Partner Content
Monoclonal Antibodies: A Good Place To Be In The Time Of Covid-19 And Stock Market Bubbles
Sep 15 / Seeking Alpha - Paid Partner Content
2 Healthcare Stocks That Are Better Value Buys Than Apple
Sep 09 / MotleyFool.com - Paid Partner Content
EMA accepts Bristol Myers application for O+Y for first-line treatment of type of lung cancer
Sep 15 / Seeking Alpha - Paid Partner Content
Celgene CVR down 24% on potential delay in key approval
Sep 08 / Seeking Alpha - Paid Partner Content